A study to fine efficacy of two Ayurvedic drugs in the treatment of pain and swelling of joints occurring after chikungunya fever.

Efficacy of Punarnava Guggulu and Sanjivani Vati in the management of Post Chikungunya Chronic Inflammatory Rheumatism -An Open Labelled Randomized Comparative Clinical Trial

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/02/017659

Enrollment

Registered

2019-02-14

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: A920- Chikungunya virus disease

Interventions

Intervention1: Punarnava Guggulu: 3 Vati (300 mg each) of Punarnava Guggulu will be given thrice a Day with warm water after meal Control Intervention1: Sanjivani Vati: 2 Vati (125 mg each) of sanjiva

Eligibility

Inclusion criteria

Inclusion criteria: 1.Confirm case of Chikungunya fever with symptoms of pCHIK-CIR. 2.Patient willing to participate in the trial.

Exclusion criteria

Exclusion criteria: 1.Age below 18 years & above 60 years. 2.Pregnant and lactating women 3. History of RA, Gout, Psoriatic arthritis, rheumatic fever, autoimmune disease, thyroid dysfunction, sarcoidosis, SLE before Chikungunya fever. 4.Patients suffering from: Malignant and accelerated hypertension, coronary artery disease, uncontrolled diabetes. • Patient undergoing regular treatment for any other severe illness and also patients suffering from pulmonary tuberculosis, bone tuberculosis, carcinoma and HIV positive patients.

Design outcomes

Primary

Measure	Time frame
efficacyTimepoint: 2 months	—

Secondary

Measure	Time frame
safetyTimepoint: 2 months	—

Countries

India

Contacts

Public ContactDrMandip Goyal

Institute for Post Graduate Teaching & Research in Ayurveda

kaurmandip22@yahoo.com9998545678

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026